Table 5 Multivariate analysis of the impact of PH treatment on BPD.

From: Inhaled nitric oxide as an independent intervention to lower the risk of bronchopulmonary dysplasia in preterm infants (< 33 weeks) with pulmonary hypertension within the initial 3 days of life

Medication

β Coefficient (Log Odds)

OR

95%Cl

Wald χ²

P-value

iNO

− 2.41

0.09

0.02–0.45

8.43

0.004

Milrinone

0.64

1.9

0.43–8.32

0.72

0.39

Sildenafil

− 1.24

0.29

0.07–1.24

2.78

0.1

PS

− 1.66

0.19

0.05–0.77

5.37

0.02

  1. PS = Pulmonary surfactant; BPD = Bronchopulmonary Dysplasia; PH = Pulmonary Hypertension; OR = Odds Ratios; 95% cl = 95% Confidence Intervals.
Back to article page